Flatiron's Chief of #AI, Will Shapiro, recently participated in a thought-provoking panel discussion at the Clinical Pathways Congress on "Digital Innovation: Cancer-Specific AI Use Cases." Curious about how AI is shaping the future of cancer care? We've distilled our key insights below. 🔗 Read the full article here: https://lnkd.in/eXyRkVki
Flatiron Health
Biotechnology Research
New York, New York 78,744 followers
Reimagining the infrastructure of cancer care
About us
Flatiron Health’s mission is to improve and extend lives by learning from the experience of every person with cancer.
- Website
-
http://www.flatiron.com
External link for Flatiron Health
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- New York, New York
- Type
- Privately Held
Locations
-
Primary
233 Spring St
5th Floor
New York, New York 10013, US
Employees at Flatiron Health
Updates
-
Flatiron Health reposted this
Don't Miss the Technology Innovation Showcase by Flatiron Health at #RR24! Join Molly Lieber and Cortney Bruno from Flatiron Health as they dive into the latest innovations in clinical trial technology and academic partnerships. Stop by Booth #3 for a firsthand look at how Flatiron is transforming the future of healthcare. Learn more here: https://bit.ly/3Y6uvZs
-
Experts from Flatiron Health’s research network team will be at Florence Healthcare's #RR24, participating in focused conversations on how innovative technology can support site workflows, when to consider eSource, and how we can all learn from each other. Visit our team in the Exhibit Hall, or join us at our Innovation Technology Showcase on Tuesday. If you can't make it to Atlanta next week and want to learn more about how we work with research sites, connect with us here: https://lnkd.in/eph8Dvcr
1 WEEK LEFT 'TIL RESEARCH REVOLUTION 2024! Are you ready?
-
We're on a mission to improve and extend lives by learning from the experience of every person with cancer. Solve problems that matter by joining our growing community of changemakers in the Raleigh-Durham area. Apply today: https://shorturl.at/LeL8B
-
Join speakers from University of Pennsylvania, Caris Life Sciences, and Flatiron Health on October 10th for a discussion on the pivotal role that high-quality linked clinical and multiomics #RWD plays in accelerating all stages of drug development to maximize the success of novel therapeutics. Register today: http://spkl.io/6044fzhn8
-
Join Flatiron Health for the Association for Value-Based Cancer Care conference this October in NYC to explore the future of value-based cancer care. #AVBCC2024 Attend expert panels on critical topics in oncology care, including data-driven management, quality measures, AI applications, value-based agreements, and pediatric care. To connect directly with our team onsite, visit our exhibit table or schedule a meeting today: https://lnkd.in/egnYrU-g
-
Interested in learning more about the power of #RWD and molecular profiling technology? Join our upcoming panel discussion: Accelerating Precision Oncology Research With Linked Clinical and Multiomic Real World Data https://lnkd.in/e3dgCQNw
Over the past 25 years, #cancerresearch and clinical practice has evolved dramatically, moving from one-size-fits-all treatments to personalized therapies driven by molecular profiling. Today, precision oncology, fueled by advances in biomarker testing and linked real-world data, is transforming patient care. Flatiron’s Director of Scientific Engagement, Precision Oncology, Kristi M. Zimmerman Savill, PhD shares her perspective on how advances in molecular profiling technology and linked real-world clinico-omics data are shepherding a new era of precision oncology research in a recent article. https://lnkd.in/eDqyatKF
-
Over the past 25 years, #cancerresearch and clinical practice has evolved dramatically, moving from one-size-fits-all treatments to personalized therapies driven by molecular profiling. Today, precision oncology, fueled by advances in biomarker testing and linked real-world data, is transforming patient care. Flatiron’s Director of Scientific Engagement, Precision Oncology, Kristi M. Zimmerman Savill, PhD shares her perspective on how advances in molecular profiling technology and linked real-world clinico-omics data are shepherding a new era of precision oncology research in a recent article. https://lnkd.in/eDqyatKF
-
Tomorrow at #SCDM2024: Join Flatiron Health medical director Anosheh Afghahi at 12PM ET to hear her clinical perspective on the current state of EHR-to-EDC technology, including both successes and ongoing challenges to address. 👨🔬 Rajesh Modi, Merck; Cal Collins and Andrew Wyman, OpenClinica; Manny Vazquez, CCDM, Veeva Systems Not on-site but want to learn more? Reach out to the team today: https://lnkd.in/e4bafP_m
-
Advances in biomarker testing, analytical methods, and real-world datasets that include biomarker and clinical data are rapidly enhancing precision oncology, enabling both forward and reverse translation and allowing for more effective patient-specific treatments. Join a panel of experts from Caris Life Sciences & University of Pennsylvania School of Medicine to explore the evolving state of precision oncology research and the pivotal role that high-quality linked clinical and multiomics RWD plays in accelerating all stages of drug development to maximize the success of novel therapeutics. ⬇️ Secure your spot & ask our panel of experts your questions directly. Register now: http://spkl.io/6046fJmSK